Market revenue in 2023 | USD 71.9 million |
Market revenue in 2030 | USD 126.9 million |
Growth rate | 8.5% (CAGR from 2023 to 2030) |
Largest segment | Proteases |
Fastest growing segment | Proteases |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Proteases |
Key market players worldwide | Biocatalysts Ltd, Merck KGaA, Codexis Inc, Roche Holding AG, Amano Enzyme, Advanced Enzymes, Amicogen, Dyadic International Inc, BBI Solutions, Affymetrix, American Laboratories, Inc. |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in-vitro diagnostics enzymes market will help companies and investors design strategic landscapes.
Proteases was the largest segment with a revenue share of 100% in 2024. Horizon Databook has segmented the Middle East & Africa in-vitro diagnostics enzymes market based on proteases covering the revenue growth of each sub-segment from 2018 to 2030.
High incidence rate of infectious diseases and other clinical disorders in MEA is boosting the demand for IVD enzymes in the region. For instance, 2019 publications of the South African Medical Journal indicate that RT-PCR has been found effective in the diagnosis of hemophilia A in South Africa.
Due to limited resources and lack of known data for hemophilia A, the disease is largely underdiagnosed in South Africa. Thus, researchers have developed a PCR-based method for the detection of Intron 22 inversion—a mutation that accounts for approximately 45% of all severe hemophilia A cases.
This method also involves sequencing to confirm results obtained from PCR. R&D for the development of such tests is expected to increase the adoption rate of molecular IVDs in South Africa, thereby propelling market growth.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa in-vitro diagnostics enzymes market, including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa in-vitro diagnostics enzymes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account